A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Explore 11592 conditions in our directory, and growing.
Condition name for this article.

Nonalcoholic steatohepatitis

Other Names: NASH, Non-alcoholic steatohepatitis, Metabolic dysfunction-associated steatohepatitis, MASH, Steatohepatitis, nonalcoholic, Steatohepatitis, non-alcoholic.
Causes Symptoms Treatment Prognosis Lifestyle FAQ

At a Glance

Nonalcoholic steatohepatitis is a progressive liver disease characterized by liver inflammation and cell damage caused by a buildup of fat in people who drink little or no alcohol, potentially leading to scarring and permanent damage (cirrhosis).
While it is most commonly diagnosed in middle-aged adults between 40 and 60 years old, the condition is becoming increasingly common in children and young adults due to rising rates of obesity.
It is a chronic condition that typically develops silently over years but can often be managed or reversed in its early stages before severe scarring occurs.
The outlook is generally favorable if diagnosed early and managed with lifestyle changes, but it carries a serious risk of progressing to liver failure or liver cancer if significant scarring develops.

See Your Ranked Personalized Treatments

A graphic depicting a sample medication report that registered members can run.
Impact in abdominal area.

How It Affects You

Nonalcoholic steatohepatitis primarily affects the liver, a vital organ located in the upper right side of the abdomen. This condition causes excess fat to build up in liver cells, triggering inflammation and cellular damage that can impair the liver's ability to filter blood and produce essential proteins. Over time, this chronic injury can lead to several serious changes in the body:

  • Scar tissue formation: Continuous inflammation causes the liver to develop fibrous scars, eventually leading to stiffness and reduced function.
  • Fluid accumulation: Advanced damage can disrupt blood flow, causing fluid to leak into the abdomen and swelling in the legs.
  • Systemic metabolic strain: The liver's reduced efficiency can worsen insulin resistance and cholesterol levels, affecting the entire body's metabolism.

.

Causes and Risk Factors

Underlying Causes
Nonalcoholic steatohepatitis occurs when excess fat accumulation in the liver (steatosis) becomes toxic to liver cells. Unlike simple fatty liver, where fat sits harmlessly, this condition involves a "second hit" where the fat triggers inflammation and oxidative stress. This process kills liver cells and activates the body's repair mechanisms, which lay down scar tissue (fibrosis) in an attempt to heal the injury. The exact reason why some people with fatty liver develop this aggressive inflammation while others do not is not fully understood, but it is closely linked to how the body handles insulin and fat.

Risk Factors
Several factors significantly increase the likelihood of developing this condition. The strongest drivers are related to metabolic health. Common risk factors include:

  • Obesity: particularly carrying excess weight around the waist (central obesity).
  • Type 2 diabetes: or prediabetes, as insulin resistance drives fat storage in the liver.
  • Abnormal blood fats: having high triglycerides or high LDL (bad) cholesterol.
  • Metabolic syndrome: a cluster of conditions including high blood pressure, high blood sugar, and excess body fat.
  • Sleep apnea: untreated sleep disorders are increasingly linked to liver inflammation.

Prevention
Primary prevention focuses on maintaining a healthy metabolic profile. Maintaining a healthy weight through a balanced diet and regular physical activity is the most effective way to prevent liver fat accumulation. For those who already have risk factors like diabetes or high cholesterol, keeping these conditions under strict control with the help of a healthcare provider is essential. While there are no vaccines to prevent this specific condition, vaccinating against hepatitis A and B is recommended to protect the liver from additional stress.

A graphic depicting a sample medication report that registered members can run.
.

Diagnosis, Signs, and Symptoms

Signs and Symptoms
Nonalcoholic steatohepatitis is often called a "silent" disease because most people have no symptoms for many years, even as liver damage progresses. When symptoms do appear, they are often vague and non-specific. In early or moderate stages, individuals may experience:

  • Fatigue: A persistent sense of tiredness or weakness that does not improve with rest.
  • Abdominal discomfort: A dull ache or mild pain in the upper right side of the abdomen, just below the ribs.
If the disease progresses to cirrhosis (severe scarring), more distinct signs may develop, including yellowing of the skin and eyes (jaundice), dark urine, swelling in the legs and abdomen, and easy bruising or bleeding.

How Clinicians Identify the Condition
Because symptoms are rare, the condition is often discovered incidentally during routine blood tests. A diagnosis typically involves a combination of methods:

  • Blood tests: Doctors look for elevated liver enzymes (ALT and AST), which indicate liver inflammation.
  • Imaging: Ultrasound, CT scans, or MRI scans are used to visualize fat in the liver. Specialized ultrasounds (like transient elastography) can measure liver stiffness to estimate scarring.
  • Liver biopsy: This is the gold standard for diagnosis. A small sample of liver tissue is removed and examined under a microscope to confirm the presence of inflammation and ballooning liver cells, which distinguishes this condition from simple fatty liver.

Differential Diagnosis
Clinicians must rule out other causes of liver disease before confirming this diagnosis. They will verify that the patient does not drink significant amounts of alcohol, as alcohol-associated liver disease looks nearly identical under a microscope. They will also test for viral hepatitis (Hepatitis B and C), autoimmune liver diseases, and reactions to certain medications.

.

Treatment and Management

Lifestyle and Self-Care Strategies
The cornerstone of management is lifestyle modification, which targets the underlying metabolic drivers of the disease. Weight loss is the most effective treatment; losing between 7% and 10% of total body weight can reduce inflammation and even reverse some scarring. Recommended strategies include:

  • Dietary changes: Adopting a Mediterranean-style diet rich in fruits, vegetables, whole grains, and healthy fats (like olive oil) while reducing saturated fats, added sugars (especially fructose), and refined carbohydrates.
  • Physical activity: Engaging in moderate aerobic exercise (like brisk walking) and resistance training for at least 150 minutes per week helps improve insulin sensitivity and burn liver fat.
  • Alcohol avoidance: Eliminating alcohol consumption is crucial to prevent further stress on the liver.

Medical Treatments
While lifestyle changes are the first line of defense, medical interventions are playing a growing role. Doctors focus on aggressively managing co-existing conditions like diabetes, high blood pressure, and high cholesterol using standard medications, as this helps protect the liver. Recently, new medications specifically designed to reduce liver fat and fibrosis have been approved for certain patients with moderate to advanced scarring. Vitamin E supplements may be considered for some non-diabetic patients, but this should only be done under medical supervision due to potential risks.

When to See a Doctor
Regular monitoring is essential for anyone with this diagnosis. Patients should schedule routine follow-ups to check liver enzyme levels and monitor for signs of progression. Immediate medical attention should be sought if "red-flag" symptoms appear, such as:

  • Yellowing of the skin or whites of the eyes.
  • Sudden or severe abdominal pain.
  • Vomiting blood or passing black, tarry stools.
  • Unexplained mental confusion or extreme drowsiness.

A graphic depicting a sample medication report that registered members can run.
.

Severity and Prognosis

Severity and Disease Course
Nonalcoholic steatohepatitis is a serious form of liver disease that indicates active injury is occurring. The severity is generally graded by the amount of fibrosis (scarring) present in the liver. The disease typically follows a slow course over many years. Many patients remain stable, but a subset will progress through four stages of scarring: from no scarring, to mild fibrosis, to bridging fibrosis, and finally to cirrhosis. Once cirrhosis develops, the liver becomes permanently damaged and stiff, significantly altering the body's function.

Complications
The most significant risk is the progression to cirrhosis, which can lead to liver failure. Complications of advanced disease include:

  • Portal hypertension: High blood pressure in the liver's vein system, leading to varicose veins in the esophagus (varices) that can bleed.
  • Ascites and Edema: Fluid buildup in the abdomen and legs.
  • Liver Cancer: Chronic inflammation and cell turnover increase the risk of developing hepatocellular carcinoma, a type of primary liver cancer.
  • Cardiovascular Disease: Interestingly, heart disease—not liver failure—is the leading cause of death in people with this condition due to the shared risk factors like obesity and diabetes.

Prognosis
The prognosis depends heavily on the stage of fibrosis at the time of diagnosis. If the condition is identified early (before significant scarring), lifestyle changes can halt and often reverse the damage, leading to a normal life expectancy. However, once advanced fibrosis or cirrhosis is present, the risk of liver-related complications increases, potentially shortening life expectancy without successful treatment or liver transplantation. Modern diagnostic tools allow for earlier detection, which significantly improves long-term outcomes.

.

Impact on Daily Life

Impact on Daily Activities and Well-being
For many, the condition does not physically limit daily activities in the early stages. However, fatigue is a common complaint that can affect work performance and social energy. As the focus of treatment is often major lifestyle change, patients may face practical and social challenges related to diet and exercise. Social gatherings involving food or alcohol can become sources of stress. Patients may also experience anxiety regarding the potential for disease progression, especially since the condition is "silent." Building a support system and focusing on the positive control one has through lifestyle changes can be empowering.

Questions to Ask Your Healthcare Provider
To better understand your condition and take an active role in your care, consider asking the following questions at your next appointment:

  • What stage of fibrosis (scarring) do I currently have?
  • Is my liver damage reversible at this stage?
  • How much weight specifically should I aim to lose, and what is a safe timeframe?
  • Are there any new medications appropriate for my specific stage of disease?
  • How often do I need imaging tests to screen for liver cancer?
  • Are the other medications I take for different conditions safe for my liver?
  • Should I consult a dietitian or a hepatologist (liver specialist)?

A graphic depicting a sample medication report that registered members can run.
.

Common Questions and Answers

Q: Is nonalcoholic steatohepatitis reversible?
A: Yes, in many cases, especially in the early stages. The liver has a remarkable ability to repair itself. If you lose weight and control your blood sugar and cholesterol, the inflammation can subside, and mild scarring can heal. However, advanced cirrhosis is generally considered permanent and irreversible.

Q: Can I drink alcohol if I have this condition?
A: Doctors typically recommend avoiding alcohol completely. Since your liver is already under stress from inflammation and fat buildup, even small amounts of alcohol can accelerate damage and speed up the progression to cirrhosis.

Q: Is this condition hereditary?
A: Genetics do play a role. Certain genetic variations can make some people more susceptible to liver fat accumulation and inflammation, even if they are not severely overweight. However, lifestyle factors like diet and activity level remain the biggest drivers of the disease.

Q: What is the difference between "fatty liver" and this condition?
A: "Simple fatty liver" (steatosis) means there is fat in the liver, but no inflammation or cell damage. Nonalcoholic steatohepatitis involves fat plus inflammation and damage. The latter is much more serious because it can lead to scarring, whereas simple fatty liver typically does not cause long-term liver damage.

Q: Are there specific foods I should eat to help my liver?
A: While no single "superfood" cures the liver, coffee (black, without sugar) has been shown in studies to be beneficial for liver health. Beyond that, a diet low in processed carbohydrates and high in fiber, healthy fats (like avocados and nuts), and lean proteins is best.

Content last updated on February 12, 2026. Always consult a qualified health professional before making any treatment decisions or taking any medications. Review our Terms of Service for full details.